---
title: "Copper Nanoclusters"
---
# Copper Nanoclusters
`technology · nanomaterial · diagnostic · fluorescent · CRISPR · sustainable`

Last modified 2026-06-06 · 2 papers · 3 incoming links · E. coli, [[CRISPR-Cas12a]], [[EGFR-L858R]]

| | |
|---|---|
| **Type** | Fluorescent nanomaterial |
| **Synthesis method** | DNA-templated, one-pot synthesis |
| **Key properties** | High photostability, large Stokes shift |
| **Template advantage** | Enhanced synthesis on AT-rich DNA sequences |
| **Integration platform** | [[CRISPR-Cas12a]] systems |
| **Primary applications** | Bacterial DNA detection, point-mutation detection |
| **Detection mode** | Fluorescence signal-off via collateral cleavage |
| **Papers indexed** | 2 |

---

**Copper nanoclusters (CuNCs)** are DNA-templated fluorescent nanoparticles offering sustainable, eco-friendly alternatives to conventional synthetic fluorophores in diagnostic applications.¹ Comprising small clusters of copper atoms stabilized by oligonucleotide scaffolds, CuNCs exhibit excellent optical characteristics including high photostability and large Stokes shift, enabling sensitive and cost-effective detection of bacterial pathogens and genetic mutations. The nanoclusters have been successfully integrated with the [[CRISPR-Cas12a]] system to create programmable biosensors in which target DNA recognition triggers Cas12a collateral cleavage of the DNA templates supporting nanocluster formation, resulting in a marked decrease in fluorescence intensity.¹ A key advantage of CuNCs is their enhanced synthesis efficiency on AT-rich DNA sequences, a property leveraged to suppress fluorescence interference from residual genomic DNA and non-specific amplification products in diagnostic workflows.²

---

## Mechanism

Copper nanoclusters are synthesized through a one-pot process in which copper ions nucleate at specific positions along DNA scaffolds to form stable, fluorescent complexes with tunable optical properties.¹ The photophysical characteristics of CuNCs—including high quantum yield and emission wavelength—depend critically on the DNA template composition, with AT-rich sequences (such as poly-AAT arrangements) providing enhanced synthetic efficiency and stronger fluorescence output.² The nanoclusters exhibit a particularly large Stokes shift, which is the spectral separation between excitation and emission wavelengths; this property reduces background autofluorescence and substantially improves assay sensitivity in complex biological samples.¹

When integrated with the [[CRISPR-Cas12a]] system, CuNCs sensing becomes programmable and highly specific. A DNA reporter containing the nanocluster-forming template is positioned within the Cas12a/gRNA ribonucleoprotein complex. Upon recognition and binding of the target DNA sequence, the Cas12a nuclease is activated and undergoes a conformational change that triggers collateral cleavage activity—a non-specific degradation of adjacent DNA molecules in the local environment.¹ This collateral nuclease activity cleaves the DNA templates ordinarily supporting CuNCs formation, thereby disrupting the nanocluster structure and triggering a sharp, programmable decrease in fluorescence intensity. This "signal-off" mechanism eliminates the need for fluorophore-quencher pairs or complex optical configurations.

---

## Bacterial pathogen detection

Copper nanoclusters have demonstrated strong performance in detecting bacterial nucleic acids with high specificity and sensitivity. In a comprehensive study employing CRISPR/Cas12a-integrated CuNCs, the assay achieved picomolar sensitivity and reliably detected [[E. coli]] DNA from reference laboratory strains, clinical isolates, and serum-spiked samples without requiring conventional fluorophore-quencher probes or multistep purification procedures.¹ The programmability of the Cas12a/gRNA architecture allows the same nanocluster platform to be rapidly retargeted to different bacterial pathogens simply by changing the guide RNA sequence, providing a versatile tool for emerging infectious disease surveillance.¹

A critical advantage of the AT-rich DNA reporter design is its inherent suppression of fluorescence interference. Because copper nanoclusters preferentially form on AT-rich sequences at substantially higher efficiency than on random genomic DNA templates, fluorescence output derives predominantly from the desired target amplicon rather than from residual genomic DNA or non-specific PCR products—a major source of false positives in conventional fluorescence-based diagnostics.² This selectivity enhances assay specificity without sacrificing sensitivity or requiring electrophoretic separation steps.

---

## Point-of-care mutation detection

Copper nanoclusters have been adapted for detecting single-nucleotide variations in human genetic markers, particularly [[EGFR]] mutations associated with lung cancer susceptibility and therapeutic response prediction. In a clinically validated workflow, the system integrates restriction fragment length polymorphism (RFLP) with poly-AAT-templated copper nanoclusters to detect the [[EGFR-L858R|EGFR L858R]] point mutation in whole blood samples from patients with [[non-small-cell-lung-cancer|non-small cell lung cancer]].² The assay exploits the differential digestion patterns generated when genomic DNA carrying wild-type or mutant [[EGFR]] sequences is cleaved by restriction enzymes; the resulting fragments generate distinct fluorescence signatures based on their efficiency of CuNCs formation.

A defining innovation is the integration of this system into a simplified single-tube workflow that entirely eliminates the need for gel electrophoresis. Biotin-labeled primers coupled with streptavidin-coated magnetic beads enable efficient capture and separation of digested DNA fragments within the same reaction vessel, allowing the entire analytical pipeline—PCR amplification, enzymatic digestion, magnetic bead-based separation, and fluorescence measurement—to proceed sequentially in a closed tube.² This configuration is inherently suited for miniaturization, automation, and integration into microfluidic platforms, making it highly accessible for point-of-care and remote diagnostic settings.

Clinical validation in lung cancer patients demonstrated excellent assay performance, including a linear calibration curve (r = 0.9981), recovery rates of 95–110%, and robust visual discrimination of the L858R mutation status under standard UV illumination without specialized detection instrumentation.²

---

## Cost-effectiveness and sustainability

The one-pot synthesis of copper nanoclusters from inexpensive, eco-friendly precursors and simple DNA templates renders the technology highly cost-effective compared to synthetic organic fluorophores or engineered fluorescent proteins. The rapid synthesis protocol and minimal formulation requirements make CuNCs accessible for resource-limited laboratory settings and point-of-care facilities with minimal infrastructure, directly supporting global health priorities for affordable diagnostic solutions.¹ Notably, the elimination of expensive quencher-fluorophore pairs and complex purification steps further reduces material costs while maintaining high assay sensitivity and specificity, making the platform particularly suitable for high-throughput and decentralized diagnostic deployment.

---

## References
1. PMID:41679990 — Copper nanoclusters + CRISPR/Cas12a for programmable bacterial DNA detection
2. PMID:42045108 — Specific low-interference dsDNA copper nanoclusters for visual fluorescent detection of EGFR L858R point mutation in single-tube magnetic purification system